Predictors of Survival in COPD: More than Just the FEV1

Respiratory Medicine

Volumn 102, Issue SUPPL. 1, 2008, Pages

  Celli, Bartolome R ^a   Cote, Claudia G ^b   Lareau, Suzanne C ^c   Meek, Paula M ^d  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b Bay Pines VA Medical Center   (United States)

^c NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

BODE; COPD; Functional Status; Mortality; Quality of Life

Indexed keywords

AIRWAY OBSTRUCTION; ANEMIA; ARTICLE; BODY MASS; CACHEXIA; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE SEVERITY; EXERCISE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; HYPOXEMIA; LEAN BODY WEIGHT; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SURVIVAL; UNITED STATES; VALIDATION PROCESS;

ACTIVITIES OF DAILY LIVING; DYSPNEA; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; UNITED STATES;

EID: 45849114780     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(08)70005-2     Document Type: Article

References (40)

1. Anthonisen N., Wright E., and Hodgkin J. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 133 (1986) 14-20
2. Pauwels R., Buist A., Calverley P., Jenkins C., and Hurd S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
3. Fletcher C., and Peto R. The natural history of chronic airflow obstruction. Br Med J 1 (1977) 1645-1648
4. Scanlon P., Connett J., Waller L., Altose M., Bailey W., and Buist A. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 161 (2000) 381-390
5. Casaburi R., Mahler D., Jones P., et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 19 (2002) 217-224
6. Decramer M., Celli B., Tashkin D., et al. Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: The UPLIFT trial. COPD 1 (2004) 303-312
7. Calverley P., Anderson J., Celli B., Ferguson G., Jenkins C., Jones P., Yates J., Vestbo J., and the TORCH investigators. Salmeterol and fluticasone propionate and survival in Chronic Obstructive Pulmonary Disease. N Engl J Med 356 (2007) 775-789
8. Gaissert H., Trulock E., Cooper J., Sundaresan R., and Patterson G. Comparison of early functional results after volume reduction or lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 111 (1996) 296-306 discussion 306-297
9. Fishman A., Martinez F., Naunheim K., et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 348 (2003) 2059-2073
10. Cooper C. Assessment of Pulmonary Function in COPD. Semin Respir Crit Care Med 26 2 (2005) 246-252
11. Casanova C., Cote C., de Torres J., et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 (2005) 591-597
12. Celli B., ZuWallack R., Wang S., and Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 124 (2003) 1743-1748
13. Schols A., Soeters P., Dingemans A., Mostert R., Frantzen P., and Wouters E. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 147 (1993) 1151-1156
14. Engelen M., Schols A., Baken W., Wesseling G., and Wouters E. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 7 (1994) 1793-1797
15. Schols A., Slangen J., Volovics L., and Wouters E. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1791-1797
16. Similowski T., Agusti A., MacNee W., and Schonhofer B. The potential impact of anaemia of chronic disease in COPD. Eur Respir J 27 (2006) 390-396
17. Chambellan A., Chailleux E., and Similowski T. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 128 (2005) 1201-1208
18. Cote C., Zilberberg M., Mody S., and Celli B. Anemia is a predictor of mortality in patients with COPD. Proc Am Thoracic Soc 2 (2005) A890
19. Goodnough L., and Nissenson A. Anemia and its clinical consequences in patients with chronic diseases. Am J Med 116 Suppl 7A (2004) 1S-2S
20. Pinto-Plata V., Cote C., Cabral H., Taylor J., and Celli B. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 23 (2004) 28-33
21. O'Donnell D., Fluge T., Gerken F., et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 23 (2004) 832-840
22. O'Donnell D., Voduc N., Fitzpatrick M., and Webb K. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 24 (2004) 86-94
23. O'Donnell D., Lam M., and Webb K. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158 (1998) 1557-1565
24. Guell R., Casan P., Belda J., et al. Long-term effects of outpatient rehabilitation of COPD. A randomized trial. Chest 117 (2000) 976-983
25. Nishimura K., Izumi T., Tsukino M., and Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121 (2002) 1434-1440
26. Oga T., Nishimura K., Tsukino M., Sato S., and Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease. Am R Respir Crit Care Med 167 (2003) 544-549
27. Domingo-Salvany A., Lamarca R., Ferrer M., Garcia-Aymerich J., Alonso J., Félez M., Khalaf A., et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166 (2002) 680-685
28. Martinez F., Foster G., Curtis J., Criner G., Weinmann G., Fishman A., DeCamp M., Benditt J., Sciurba F., Make B., et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 173 (2006) 1326-1334
29. Fan V., Curtis J., Tu S.-P., McDonell M., and Fihn S. Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. Chest 122 (2002) 429-436
30. Tu S., McDonnell M., Spertus J., Steele B., and Fihn S. A new self-administered questionnaire to monitor health-related quality of life in patients with COPD. Chest 112 (1997) 614-622
31. Bowen J., Votto J., Thrall R., Haggerty M., Stockdale-Wooley R., Bandyopadyay T., and ZuWallack R. Functional status and survival following pulmonary rehabilitation. Chest 118 (2000) 697-703
32. Celli B., Cote C., Marin J., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 1005-1012
33. Cote C., Casanova C., Marin J., et al. The BODE Index and the St. George's Questionnaire: Associations and Survival in COPD. Proc Am Thoracic Soc 3 (2006) A851
34. Cote C., and Celli B. Effect of exacerbations of COPD on multidimensional body mass index, airflow obstruction, dyspnea, and exercise capacity, BODE Index. Chest (2004) 840S abstract.
35. Chong W., Ong K., Soh C., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in predicting hospitalization for chronic obstructive pulmonary disease. Chest (2004) 841S abstract.
36. Celli B. Pulmonary rehabilitation for COPD. A practical approach for improving ventilatory conditioning. Postgrad Med 103 (1998) 159-160 167-158, 173-156.
37. Meek P., and Lareau S. Critical outcomes in pulmonary rehabilitation: assessment and evaluation of dyspnea and fatigue. J Rehabil Res Dev 40 (2003) 13-24
38. Garrod R., Ford K., Daly C., Hoareau C., Howard M., and Simmonds C. Pulmonary rehabilitation: analysis of a clinical service. Physiother Res Int 9 (2004) 111-120
39. Cote C., and Celli B. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 26 (2005) 630-636
40. Imfeld S., Bloch K., Weder W., and Russi E. The BODE index after lung volume reduction correlates with survival in COPD. Chest 129 (2006) 835-836